Immunity, microbiome and probiotics in viral infections

2021

Closed access Metadata (CSL-JSON)
DOI 10.33920/med-12-2108-07
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Currently, studying the role of microbiome in the realization of antiviral mechanisms is a relevant issue, especially in the context of the COVID-19 pandemic. It is known that microbiome disrupts the life cycle of viruses in the human organism cells at different stages and stimulates both innate and specific immune response. Such factors as delivery by cesarean section, artificial feeding of a child, early use of antibacterial agents, age-related changes lead to the development of dysbiosis, which increases the body’s susceptibility to viral infections. A positive role of probiotics use is observed in a range of viral infections, including HIV, HPV infection, viral hepatitis, respiratory infections and a number of other diseases.